全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2018 

Development of a Customized TaqMan?? Array Card for Simultaneous Detection of 32 Respiratory Pathogens

Keywords: Deborah Steensels, Marie-Luce Delforge, Katrien Lagrou, Kurt Beuselinck and Isabel Montesinos, TaqMan???? array card, Real-time polymerase chain reaction/methods, Respiratory tract Infections/microbiology syndromic testing, Development and validation, Sensitivity, Specificity, Reproducibility

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: Syndromic testing with a rapid and complete diagnostic panel would be extremely useful for routine respiratory testing. Objective: We developed and validated a real-time PCR-based Taqman array card (TAC) including several pathogens specific for immuno-compromised patients, using sequences designed and supported by the manufacturer. Study design: Analytical validation was performed in 2 phases. Phase 1 testing was performed in 96-well plates and included efficiency, reactivity and sensitivity testing. The assays selected after phase 1 were validated in TAC format in phase 2 which included analytical sensitivity (LoD), reactivity, specificity and reproducibility testing. Clinical validation was performed in phase 3 by testing respiratory samples that were sent to the lab between December 2016 and May 2017. Results: In total, 90 assays were tested in phase 1 of which 43 were retained for further validation in TAC format. Seven of the 43 assays did not meet the predefined criterion of efficiency ≥ 80%, but were accepted for further testing in phase 2 and 3 due to lack of alternatives. All 43 targets together detected 89% (481/539) of positives included in the reactivity testing in phase 1 and 98% (246/252) of positives in phase 2. All tested assays showed excellent analytical sensitivity, with LoD ranging from 1 to 100 copies/μL. An overall specificity of 99.96% was found. Reproducibility ranged from 76%-100%, with a mean of 91%. For the clinical validation, a total number of 428 samples were tested, with an overall positivity rate of 56.3% and a co-infection rate of 15.9%. 15 results (4% of total number of positives) were not confirmed and considered false positives. One result (0.2%) was considered false negative. Conclusion: This syndromic panel was analytically and clinically validated and will be implemented for routine respiratory testing in the Erasme University Hospital in high risk patient populations

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133